Hypertension, hyperlipidemia and microalbuminuria

Contributions to Nephrology

Volumn 120, Issue , 1997, Pages 11-21

  Campese, Vito M ^a,b   Bianchi, Stefano ^a   Bigazzi, Roberto ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; LIPID; LIPOPROTEIN;

ALBUMINURIA; BLOOD; BLOOD PRESSURE; CAROTID ARTERY; HUMAN; HYPERINSULINISM; HYPERLIPIDEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLISM; PATHOLOGY; REVIEW; SODIUM INTAKE;

ALBUMINURIA; BLOOD PRESSURE; CAROTID ARTERIES; HUMANS; HYPERINSULINISM; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; LIPIDS; LIPOPROTEINS; SODIUM, DIETARY;

EID: 0030624592     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059818     Document Type: Review

References (70)

1. Parving HH, Jensen HAE, Mogensen CE, Evrin PE: Increased urinary albumin excretion in benign essential hypertension. Lancet 1974;i:1190-1192.
2. Losito A, Fortunati F, Zampi I, Del Favero A: Impaired renal functional reserve and albuminuria in essential hypertension. BMJ 1988;296:1562-1564.
3. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Ghione S: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens 1989;2:259-261.
4. Pedersen EB, Mogensen CE: Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and renal plasma flow in patients with essential hypertension. Scand J Clin Lab Invest 1976;36:231-237.
5. Bigazzi R, Bianchi S, Campese VM, Baldari G: Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992;61:94-97.
6. Kannel WB: Hypertension and the risk of cardiovascular disease. In: Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. Raven, New York, 1990, pp 101-117.
7. Lewin A, Blaufox D, Castle H, Entwisle G, Langford H: Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-Up Program. Arch Intern Med 1985;145:424-427.
8. Samuelsson O, Wilhelmsen L, Elmfeldt D, Pennert K, Wedel H, Wikstrand J, Berglund G: Predictors of cardiovascular morbidity in treated hypertension: Results from the primary preventive trial in Goteborg, Sweden. J Hypertens 1985;3:167-176.
9. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988;ii:530-533.
10. Haffner SM, Stern MP, Gruber MKK, Hazuda HP, Mitchell BD, Patterson JK: Microalbuminuria: Potential marker for increased cardiovascular risk factor in nondiabetic subjects? Arteriosclerosis 1990;5:727-731.
11. Opsal JA, Abraham PA, Halstenson CE, et al: Correlation of office and ambulatory blood pressure measurements with urinary albumin and N-acetyl-B-D-glucosaminidase excretions in essential hypertension. Am J Hypertens 1988;1(suppl 1):117S-120S.
12. Cerasola G, Cottone S, D'Ignoto G, Grasso L, Mangano MT, Andronico G, Contorno A, Nardi E: Microalbuminuria points out early renal and cardiovascular changes in essential hypertension. Rev Lat Cardiol 1992;13:3-7.
13. Bianchi S, Bigazzi R, Baldari G, Sgherri G, Campese VM: Diurnal variation of blood pressure and microalbuminuria in essential hypertension. Am J Hypertens 1994;7:23-29.
14. Redon J, Liao Y, Lozano JV, Miralles A, Baldo E: Factors related to the presence of microalbuminuria in essential hypertension. Am J Hypertens 1994;7:801-807.
15. Nosadini R, Cipollina MR, Solini A, Sambataro M, Morocutti A, Doria A, Fioretto P, Brocco E, Muollo B, Frigato F: Close relationship between microalbuminuria and insulin resistance in essential hypertension and noninsulin dependent diabetes mellitus. J Am Soc Nephrol 1992;3:S56-S63.
16. Mimran A, Ribstein J, DuCailar G: Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994;23:1018-1021.
17. Bigazzi R, Bianchi S, Nenci R, Baldari D, Baldari G, Campese VM: Increased thickness of the carotid artery in patients with essential hypertension and microalbuminuria. J Hum Hypertens 1995;9:827-833.
18. Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ: Dietary nutrients intake and microalbuminuria in people at least 40 years old. Clin Chem 1993;39:2191-2198.
19. Basdevant A, Cassuto D, Gibault T, Raison J, Guy-Grand B: Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord 1994;18:806-811.
20. Jensen JS, Borch Johnsen K, Jensen G, Feldt Rasmussen B: Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis 1995;112:245-252.
21. Winocour PH, Harland J, Millar JP, Laker MF, Alberti KGMM: Microalbuminuria and associated risk factors in the community. Atherosclerosis 1992;93:71-81.
22. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familiar clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-1165.
23. Fauvel JP, Hadj-Aissa A, Laville M, Fadat G, Labeeuw M, Zech P, Pozet N: Microalbuminuria in normotensives with genetic risk of hypertension. Nephron 1991;57:375-376.
24. Grunfeld B, Perelstein E, Simsolo R, Gimenez M, Romero JC: Renal functional reserve and microalbuminuria in offspring of hypertensive parents. Hypertension 1990;3:257-261.
25. Keane WF, Peter JV St, Kasiske BL: Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory? Kidney Int 1992;42(suppl 38):S-134-S-141.
26. Kaysen GA: Hyperlipidemia of the nephrotic syndrome. Kidney Int 1991;39(suppl 31):S8-S15.
27. Newmark SR, Anderson CF, Donadio JV, Ellefson RD: Lipoprotein profiles in adult nephrotics. Mayo Clin Proc 1975;50:359-366.
28. Thomas ME, Freestone AL, Persaud JW, Varghese Z, Moorhead JF: Raised lipoprotein(a) [Lp(a(] levels in proteinuric patients. J Am Soc Nephrol 1990;1:344A.
29. Karådi I, Romics L, Pålos G, Domån J, Kaszås I, Hesz A, Kostner GM: Lp(a) lipoprotein concentration in serum of patients with heavy proteinuria of different origin. Clin Chem 1989;10:2121-2123.
30. Takegoshi T, Haba T, Hirai J, Kitoh C, Saga T, Yamazaki Y, Mabuchi H: Alterations of lipoprotein(a) in patients with diabetic nephropathy. Atherosclerosis 1990;83:99-100.
31. Jenkins AJ, Steel JS, Janus ED, Best JD: Increased plasma apoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 1991;40:787-790.
32. Kapelrud H, Banagstad HJ, Dahl-Jorgensen K, Berg K, Hanssen KF: Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria. BMJ 1991;303:675-678.
33. Jensen T, Stender S, Deckert T: Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type I (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988;31:142-145.
34. Kennel WB, Castelli WP, Gordon T: Cholesterol in the prediction of atherosclerotic disease: New perspectives based on the Framingham Study. Ann Intern Med 1979;90:85-91.
35. Gordon T, Kannel WB, Castelli WP, Dawber TR: Lipoproteins, cardiovascular disease and death: The Framingham Study. Arch Intern Med 1981;141:1128-1131.
36. Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL: Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986;256:2540-2544.
37. Scanu AM: Lipoprotein (a): A genetic risk factor for premature coronary heart disease. JAMA 1992;267:3326-3329.
38. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204.
39. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A: Lipoprotein (a) and asymptomatic carotid artery disease: Evidence of a prominent role in the evolution of advanced carotid plaques: The Bruneck Study. Stroke 1995;26:1582-1587.
40. Keane WK: Lipids and the kidney. Kidney Int 1994;46:910-920.
41. Keane WF, Kasiske BL, O'Donnel MP, Kim Y: Hypertension, hyperlipidemia and renal damage. Am J Kidney Dis 1993;21(suppl 2):43-50.
42. Mulec H, Johnson SA, Bjorek S: Relationship between serum cholesterol and diabetic nephropathy. Lancet 1990;i:1537-1538.
43. Tolins JP, Stone BG, Raij L: Interactions of hypercholesterolemia and hypertension in initiation of glomerular injury. Kidney Int 1992;41:1254-1261.
44. Keane WF, Mulcahy WS, Kasiske BL, Kim Y, O'Donnell MP: Hyperlipidemia and progressive renal disease. Kidney Int 1991;39(suppl 31):S41-S48.
45. Kasiske BL, O'Donnell MP, Cowardin W, Keane WF: Lipids and the kidney. Hypertension 1990;15:443-450.
46. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 1988;318:1657-1666.
47. Alderson LM, Endemann G, Lindsey S, Pronczuk A, Hoover RL, Hayes KC: LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol 1986;123:334-342.
48. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S: Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-357.
49. Swislocki AL, Hoffman BB, Reaven GM: Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989;2:419-423.
50. Berglund G, Larsson B, Andersson O, Larsson O, Svardsudd K, Bjorntorp P, Wilhelmsen L: Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med Scand 1976;200:163-169.
51. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989;320:702-706.
52. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H: Coronary heart disease risk and impaired glucose tolerance: The Whitehall Study. Lancet 1980;i:1373-1376.
53. Pyorala K, Uusitupa M, Laakso M, Siitonen O, Niskanen L, Ronnemaa T: Macrovascular complications in relation to hyperinsulinemia in noninsulin dependent diabetes mellitus. Diabetes Metab 1987;13:345-349.
54. Welbon TA, Wearne K: Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2:154-160.
55. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE: Coronary heart disease plasma insulin levels: The Paris prospective study, ten years later. Horm Metab Res 1985;15(suppl):41-46.
56. Ducimetiere P, Eschwege R, Papoz L, Richard JL, Claude JR, Rosselin G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 1980;19:205-210.
57. Stern MP, Haffner SM: Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 1986;6:123-130.
58. Bianchi S, Bigazzi R, Valtriani C, Chiapponi I, Sgherri G, Baldari G, Natali A, Ferrannini E, Campese VM: Elevated serum insulin levels in patients with essential hypertension and microalbuminuria. Hypertension 1994;23:681-687.
59. Kuusisto J, Mykkanen L, Pyorealea K, Laakso M: Hyperinsulinemia microalbuminuria: A new risk indicator for coronary heart disease. Circulation 1995;91:831-837.
60. Fauvel JP, Hadj-Aissa A, Laville M, Fadat G, Labeeuw M, Zech P, Pozet N: Microalbuminuria in normotensives with genetic risk of hypertension. Nephron 1991;57:375-376.
61. Grunfeld B, Perelstein E, Simsolo R, Gimenez M, Romero JC: Renal functional reserve and microalbuminuria in offspring of hypertensive parents. Hypertension 1990;15:257-261.
62. Seaquist ER, Goetz FC, Rich S, Barbosa J: Familial clustering of diabetic kidney disease: Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989;320:1161-1165.
63. Bigazzi R, Bianchi S, Baldari G, Campese VM: Clustering of cardiovascular risk factors in salt-sensitive patients with essential hypertension: Role of insulin. Am J Hypertens 1996;9:24-32.
64. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R: Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients. Atherosclerosis 1988;70:253-261.
65. Haapanen A, Koskenvuo M, Kaprio J, Kesaniemi YA, Heikkila K: Carotid atherosclerosis in identical twins discordant for cigarette smoking. Circulation 1989;80:10-16.
66. Salonen JT, Salonen R: Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-1249.
67. Rossi GP, Rossi A, Zanin L, Calabro A, Feltrin GP, Pessina AC, et al: Excess prevalence of extracranial carotid artery lesions in renovascular hypertension. Am J Hypertens 1992;5:8-15.
68. Wendelhag I, Wirklund O, Wikstrand J: Arterial wall thickness in familial hypercholesterolemia: Ultrasound measurement of intima-media thickness in the common carotid artery. Arterioscler Thromb 1992;12:70-77.
69. Campese VM, Parise M, Karubian F, Bigazzi R: Abnormal renal hemodynamics in black salt-sensitive patients with hypertension. Hypertension 1991;18:805-812.
70. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients: A marker for renal and cardiovascular risk factors. Hypertension 1994;23:195-199.